Delivery Order SPE2DB22D1017-SPE2DB24FF7KU
Award Date
5/8/24
Potential Completion Date
5/9/24
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product. The contract has a ceiling value of $2,253.24 and runs through March 12, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $1,153.33, is for the supply of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product. The contract has a firm-fixed price pricing type and a completion date of July 31, 2024. AmerisourceBergen is a large pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,407.06, is for the delivery of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product, under a Firm Fixed Price delivery order contract. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of AMNESTEEM 40 MG CAPSULE 30S. The contract has a ceiling value of $1,488.16 and runs through March 5, 2025. It is a firm-fixed-price contract, with no set-aside designation indicated. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award to Amerisourcebergen Drug Corp for $1,051.26 is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract. The contract is for the supply of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product. The contract has no set-aside designation and is expected to be completed by August 21, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and indefinite delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,024.93 Delivery Order is for the supply of AMNESTEEM 40 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of September 23, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with the DLA Troop Support Medical for delivering a range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,204.61 firm fixed-price delivery order contract is for the supply of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of December 18, 2024 and was awarded on December 17, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999...
This federal contract award, valued at $2,712.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AMNESTEEM 40 MG CAPSULE 30S, a medical product, and has a period of performance through February 24, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $3,752.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AMNESTEEM 40 MG CAPSULE 30S, a pharmaceutical product, with a completion date of February 28, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,549.32 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide AMNESTEEM 20 MG CAPSULE 30S, a pharmaceutical product, with a completion date of February 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through...